Glaxosmithkline Pharma likely to restore dealer margins to boost sales

Jan 15 2014, 11:52 IST
Comments 0
On December 16, GlaxoSmithKline Plc had announced it wanted to raise its equity stake, in the Indian arm, to 75% from 50.7%. On December 16, GlaxoSmithKline Plc had announced it wanted to raise its equity stake, in the Indian arm, to 75% from 50.7%.
SummaryGSK has seen sales flag after reducing margins for wholesalers and retailers.

which plunged nearly 41.5%, recording sales of Rs 17.3 crore. Mumbai-based GSK Pharma's share price fell about 1.5% from early June to December 15. After the announcement of the open offer, the share price has jumped nearly 21%. On Tuesday, the stock closed at R2,978.20 on the Bombay Stock Exchange.

Single Page Format
Ads by Google

More from Frontpage

Reader´s Comments
| Post a Comment
Please Wait while comments are loading...